Four SPR® Abstracts Honored with Awards at 24th Annual ASRA Pain Meeting

CLEVELAND, Nov. 13, 2025 (GLOBE NEWSWIRE) -- SPR will have a significant presence at the upcoming annual ASRA Pain Medicine ...

The American Society of Pain and Neuroscience (ASPN) Issues Consensus Guidelines on Peripheral Nerve Stimulation

Guidelines support increasing treatment access for patients given the clinical evidence in addressing chronic pain -CLEVELAND ...
FOX8 Cleveland

SPR Announces Presentation of Four Abstracts Featuring the SPRINT® PNS System at NANS 2025

CLEVELAND, Jan. 30, 2025 (GLOBE NEWSWIRE) -- SPR announces four featured abstracts that will be presented at the upcoming North American Neuromodulation Society (NANS) Annual Meeting in Orlando, ...
Insurancenewsnet.com

Peripheral Nerve Stimulation With the SPRINT® System in Chronic Posterior Sacroiliac Joint Complex Pain: Musculoskeletal Diseases and Conditions – Lower Back Pain

Current Primary Outcome Measures •Numeric Rating Scale at 60 days and 90 days post procedure (lead removal) [ Time Frame: at 60 days (plus or minus 5 days) and 90 days (plus or minus 10 days) ] ...
WDTN

New SPRINT extensa XT™ System with Bimodal PNS™ Offers Synergistic Treatment of Pain

CLEVELAND, Ohio, April 25, 2023 (GLOBE NEWSWIRE) -- SPR ® Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or ...
Seeking Alpha

SPR® Therapeutics Announces $85 Million in Additional Funding to Advance Rapid Commercial Expansion of the SPRINT® PNS System

CLEVELAND, Feb. 01, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or chronic pain, ...
Morningstar

SPRINT® PNS Meets Primary Endpoint of Reduction in Head Pain in First Publication of Multicenter Prospective MONARCH™ Study

Our SPRINT ® PNS System fulfills a critical unmet need for a drug-free, surgery-free option for millions who suffer from chronic pain. Backed by the largest body of clinical evidence in peripheral ...